These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Current and emerging treatments for vitiligo. Rodrigues M; Ezzedine K; Hamzavi I; Pandya AG; Harris JE; J Am Acad Dermatol; 2017 Jul; 77(1):17-29. PubMed ID: 28619557 [TBL] [Abstract][Full Text] [Related]
44. Watchmaker's pin-vise for manual tattooing of vitiligo. Singal A; Thami GP; Bhalla M Dermatol Surg; 2004 Feb; 30(2 Pt 1):203-4. PubMed ID: 14756650 [TBL] [Abstract][Full Text] [Related]
45. Emotional benefit of cosmetic camouflage in the treatment of facial skin conditions: personal experience and review. Levy LL; Emer JJ Clin Cosmet Investig Dermatol; 2012; 5():173-82. PubMed ID: 23152694 [TBL] [Abstract][Full Text] [Related]
46. Vitiligo treatment demystified: a flowchart for stratified treatment approaches. Tung R; Le Poole IC Exp Dermatol; 2014 Jul; 23(7):469-70. PubMed ID: 24806714 [TBL] [Abstract][Full Text] [Related]
47. Quality of Life Impairment in Children and Adults with Vitiligo: A Cross-Sectional Study Based on Dermatology-Specific and Disease-Specific Quality of Life Instruments. Catucci Boza J; Giongo N; Machado P; Horn R; Fabbrin A; Cestari T Dermatology; 2016; 232(5):619-625. PubMed ID: 27603174 [TBL] [Abstract][Full Text] [Related]
48. Significant immediate and long-term improvement in quality of life and disease coping in patients with vitiligo after group climatotherapy at the Dead Sea. Krüger C; Smythe JW; Spencer JD; Hasse S; Panske A; Chiuchiarelli G; Schallreuter KU Acta Derm Venereol; 2011 Mar; 91(2):152-9. PubMed ID: 21240455 [TBL] [Abstract][Full Text] [Related]
49. Social Anxiety and Quality of Life in Vitiligo and Acne Patients with Facial Involvement: A Cross-Sectional Controlled Study. Salman A; Kurt E; Topcuoglu V; Demircay Z Am J Clin Dermatol; 2016 Jun; 17(3):305-11. PubMed ID: 26818062 [TBL] [Abstract][Full Text] [Related]
50. Treatment of vitiligo: advantages and disadvantages, indications for use and outcomes. Hossani-Madani A; Halder R G Ital Dermatol Venereol; 2011 Oct; 146(5):373-95. PubMed ID: 21956273 [TBL] [Abstract][Full Text] [Related]
51. Medical pearl: DHA application for camouflaging segmental vitiligo and piebald lesions. Suga Y; Ikejima A; Matsuba S; Ogawa H J Am Acad Dermatol; 2002 Sep; 47(3):436-8. PubMed ID: 12196756 [No Abstract] [Full Text] [Related]
52. Quality of life impairment in children and adolescents with vitiligo. Silverberg JI; Silverberg NB Pediatr Dermatol; 2014; 31(3):309-18. PubMed ID: 24304125 [TBL] [Abstract][Full Text] [Related]
53. Ultrathin split-thickness skin grafting followed by narrowband UVB therapy for stable vitiligo: an effective and cosmetically satisfying treatment option. Majid I; Imran S Indian J Dermatol Venereol Leprol; 2012; 78(2):159-64. PubMed ID: 22421646 [TBL] [Abstract][Full Text] [Related]
54. Vitiligo is not a cosmetic disease. Ezzedine K; Sheth V; Rodrigues M; Eleftheriadou V; Harris JE; Hamzavi IH; Pandya AG; J Am Acad Dermatol; 2015 Nov; 73(5):883-5. PubMed ID: 26475548 [No Abstract] [Full Text] [Related]
55. Vitiligo. Pathogenesis and treatment. Njoo MD; Westerhof W Am J Clin Dermatol; 2001; 2(3):167-81. PubMed ID: 11705094 [TBL] [Abstract][Full Text] [Related]
56. Effect of vitiligo on self-reported health-related quality of life. Ongenae K; Van Geel N; De Schepper S; Naeyaert JM Br J Dermatol; 2005 Jun; 152(6):1165-72. PubMed ID: 15948977 [TBL] [Abstract][Full Text] [Related]
57. Cumulative life course impairment in vitiligo. Krüger C; Schallreuter KU Curr Probl Dermatol; 2013; 44():102-17. PubMed ID: 23796814 [TBL] [Abstract][Full Text] [Related]
59. [Vitiligo as an aesthetic problem. Noninvasive therapeutic methods in vitiligo]. Popko M; Kacalak-Rzepka A; Bielecka-Grzela S; Wesołowska J; Klimowicz A; Maleszka R Ann Acad Med Stetin; 2011; 57(3):23-7. PubMed ID: 23383544 [TBL] [Abstract][Full Text] [Related]
60. Role of cosmetic camouflage in improving quality of life in dermatological disorders: A narrative review. Arora A; Bhalla M Indian J Dermatol Venereol Leprol; 2024 Jul; ():1-8. PubMed ID: 39152815 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]